The latest cancer drugs news
Browsing: Cancer Drug News
Precision drug olaparib may be effective without hormone therapy for some men with biochemically recurrent prostate cancer
The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying…
FDA approves lazertinib with amivantamab-vmjw for non-small lung cancer
On August 19, 2024, the Food and Drug Administration approved lazertinib (Lazcluze, Janssen Biotech, Inc.)…
FDA approves new therapy for glioma patients for first time in decades
Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with…
FDA approves blood test as a primary screening option for colorectal cancer
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has announced that the U.S.…
FDA approves vorasidenib
A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma,…
Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma
A drug that was developed to treat pancreatic cancer has now been shown to increase…
FDA approves daratumumab and hyaluronidase-fihj with bortezomib, lenalidomide, and dexamethasone for multiple myeloma
On July 30, 2024, the Food and Drug Administration approved daratumumab and hyaluronidase-fihj in combination with…
Newly improved method for anti-cancer drug detection: How tiny tumour models could transform drug testing
A team of researchers from Henan University of Science and Technology have introduced a novel…
FDA-mandated CAR-T monitoring period could be halved
In patients with diffuse large B-cell non-Hodgkin lymphoma (DLBCL), the two hallmark post-chimeric antigen receptor…
First-in-class breast cancer drug approved
The Institute of Cancer Research, London, UK, welcomes the news that a new targeted breast…